Rockwell Medical, Inc. (RMTI) P/E Ratio History
Deep ValueTrading at -4.3x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2003–2005
Loading P/E history...
P/E Ratio Analysis
As of June 21, 2026, Rockwell Medical, Inc. (RMTI) trades at a price-to-earnings ratio of -4.3x, with a stock price of $0.64 and trailing twelve-month earnings per share of $-40.81.
The current P/E is 101% below its 5-year average of 676.1x. Over the past five years, RMTI's P/E has ranged from a low of 67.2x to a high of 4389.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, RMTI trades at a 119% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, RMTI trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our RMTI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
RMTI Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
RMTI P/E vs Peers
Therapy-focused branded biopharma peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $8B | 26.8 | 1.17Best | -25% | |
| $13B | 21.9Lowest | 2.64 | -11% | |
| $5B | 54.7 | - | -86% | |
| $52B | 24.7 | 1.49 | -1%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
RMTI Historical P/E Data (2003–2005)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2005 Q4 | Dec 31 2005 | $49.17 | $0.05 | 983.4x | +45% |
| FY2005 Q3 | Sep 30 2005 | $41.69 | $0.46 | 90.8x | -87% |
| FY2005 Q2 | - | $34.65 | $0.35 | 99.2x | -85% |
| FY2005 Q1 | - | $36.08 | $0.35 | 103.3x | -85% |
| FY2004 Q4 | Dec 31 2004 | $34.65 | $0.35 | 99.2x | -85% |
| FY2004 Q3 | - | $32.78 | $0.46 | 71.3x | -89% |
| FY2004 Q2 | Jun 30 2004 | $30.91 | $0.46 | 67.2x | -90% |
| FY2004 Q1 | Mar 31 2004 | $41.69 | $0.23 | 181.3x | -73% |
| FY2003 Q4 | Dec 31 2003 | $43.89 | $0.01 | 4389.0x | +549% |
Average P/E for displayed period: 676.1x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
23+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
RMTI — Frequently Asked Questions
Quick answers to the most common questions about buying RMTI stock.
What is RMTI's P/E ratio?
Rockwell Medical, Inc. (RMTI) trailing twelve-month P/E ratio is -4.3x, based on TTM diluted EPS of $-40.81. The 5-year average P/E is 676.1x and the historical range spans 67.2x to 4389.0x.
Is RMTI stock overvalued or undervalued?
RMTI trades at -4.3x P/E, below its 5-year average of 676.1x. At the 0th percentile of its historical range (67.2x–4389.0x), the stock is priced at a discount to its own history.
Is RMTI stock expensive?
No, RMTI is not expensive on a historical basis. The current P/E of -4.3x is below the 5-year average of 676.1x and sits at the 0th percentile of its valuation range.
What is RMTI's historical P/E range?
Over the past 5 years, RMTI's P/E ratio has ranged from 67.2x to 4389.0x, with a median of 99.2x and an average of 676.1x. The current P/E of -4.3x places the stock at the 0th percentile of this range. Full historical data spans 2003–2005.
How does RMTI's P/E compare to the S&P 500?
RMTI trades at -4.3x P/E versus the S&P 500 median of 24.4x. The 118% discount to the market suggests lower growth expectations or perceived higher risk.
How does RMTI's valuation compare to Healthcare peers?
Rockwell Medical, Inc. P/E of -4.3x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is RMTI's PEG ratio?
RMTI PEG ratio is N/A, based on a P/E of -4.3x and EPS growth of -495.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is RMTI's earnings yield?
RMTI earnings yield is N/A, the inverse of its -4.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.